Financial Data and Key Metrics Changes - For fiscal year 2025, revenue reached CNY 3.98 billion, up 43.5%, with net profit attributable to ordinary shareholders at CNY 570 million, a year-on-year growth of 64.8% [4][21] - The company has achieved GAAP profitability for 16 consecutive quarters, indicating strong financial health [4] - Operating costs for the fourth quarter reached CNY 680 million, a 109.2% year-over-year increase, driven by rising referral and service fees [19] Business Line Data and Key Metrics Changes - The insurtech segment saw revenue surge by 61.3% with an operating margin of approximately 18% [4] - Insurance-related income in the fourth quarter increased 125% year-over-year to CNY 1.31 billion, while operating profits grew 42% year-over-year to CNY 160 million [9] - Medical consulting services generated CNY 260 million, and digital clinical trial sourcing income was CNY 118 million, accounting for about 10.1% of total revenue [18] Market Data and Key Metrics Changes - Approximately 490 million people have cumulatively donated CNY 72.3 billion to 3.68 million patients through the Waterdrop medical crowdfunding platform [13] - The E-Find platform partnered with 224 pharmaceutical companies and enrolled a record 14,055 patients, achieving significant growth [14][15] Company Strategy and Development Direction - The company is focusing on becoming an AI-native organization, embedding AI as a structural competitive advantage across its value chain [7][8] - Aiming for double-digit growth in both revenue and profit, the company plans to moderately increase investment in marketing and AI [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining growth momentum, highlighting the successful execution of the AI plus insurance strategy [3][4] - The company is committed to enhancing user privacy and risk control through advanced technology, ensuring data security and authenticity [13][14] Other Important Information - The board approved a cash dividend of $0.03 per ADS, totaling $10.8 million, to be paid in late April to early May [4][5] - The company has filed 72 LLM-related patent applications, indicating a strong focus on innovation and technology [5] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - In Q2 2025, the company reported quarterly revenue of RMB million, reflecting a year-over-year increase of 23.9% and a quarter-over-quarter increase of 11.2% [5][27] - Operating profit surged by 85.9% year-over-year, with operating margins improving by 3.9 percentage points [5][30] - Net profit attributable to ordinary shareholders reached RMB 140 million, up 58.7% year-over-year [30] Business Line Data and Key Metrics Changes - The insurance business saw first-year premiums reach RMB billion, up 80.2% year-over-year and 53.1% quarter-over-quarter [12] - Insurance-related revenue increased by 28.7% year-over-year [12] - The digital clinical trial solutions segment reported a revenue increase of 34.2% year-over-year, amounting to RMB 27.7 million [27] Market Data and Key Metrics Changes - The number of patients enrolled in the eFine platform reached a historical high, with nearly 1,000 patients enrolled in 2025 [6] - Cumulatively, around 480 million people donated RMB 70 billion to approximately 3,540,000 patients through the medical profiling platform [20] Company Strategy and Development Direction - The company is focused on integrating AI technology across its insurance and healthcare sectors to enhance operational efficiency and customer acquisition [5][9] - Plans to expand the use of AI in various business segments, including customer service and underwriting, are underway [9][31] - The company aims to continue enhancing its AI capabilities and operational efficiency to drive future growth [30] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the integration of AI leading to improved operational efficiency and customer acquisition [5][30] - The company is committed to creating long-term value for shareholders and society while optimizing operations for stable growth [31] Other Important Information - The Board approved a cash dividend of $10,900,000, representing a 50% increase over the previous dividend [10] - The company has repurchased approximately 55.7 million ADS for $109 million since the initiation of its share repurchase program in 2021 [11] Q&A Session Summary Question: What are the expectations for future growth in the insurance business? - Management highlighted that the insurance business is expected to continue its robust growth trajectory, driven by AI integration and enhanced customer acquisition strategies [12][14] Question: How is the company addressing operational costs? - The company noted that while operating costs increased by 18.7% year-over-year, the growth rate of costs was lower than that of revenue, indicating improved operational efficiency [28][30]